Essential hypertension rarely causes symptoms and the prevalence in the US continues to rise even as data emerges regarding the benefit of lower treatment targets for high risk patients. In this introductory program, Dr. Matt Sorrentino discusses the newly recommended categories for blood pressure, assesses how risk plays a major role in hypertension treatment and cites updated recommendations for blood pressure management in both low and high risk patients.
After completing this activity, the participant should be better able to:
1. Identify the newly recommended categories of blood pressure and cite the rationale for the new classification of hypertension.
2. Recognize how risk categories assist in decision making on hypertension treatment.
3. Outline basic essential hypertension pathophysiology and how it applies in medication selection for blood pressure control.
4. Cite recommendations for blood pressure management in low risk and high risk patients.
Estimated time to complete this activity is 1 hour.
Your CE Source ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, Your CE Source identifies conflicts of interest with its instructors, planners, content managers, and other individuals who are in a position to control the content of an activity.
All faculty, planner and/or content managers have nothing to disclose nor do they have any vested interests or affiliations.
The content, views and opinions presented in this educational activity are those of the faculty/authors and do not necessarily reflect those of Your CE Source and/or eMedEd, Inc. The faculty/authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Learners are required to adhere to the privacy and confidentiality policy as it relates to the CE activities provided on the Internet. Please see policy at https://www.yourcesource.org/index.cfm?do=cnt.page&pg=1029
Questions about continuing education credit or certificates related to this course, please contact us via email at email@example.com.
Questions about the content, please contact eMedEd, Inc. via email at firstname.lastname@example.org
This material may not be reproduced, displayed, modified or distributed without the express prior written permission of the copyright holder.
Suppose you cancel the course booking within 14 calendar days of receiving your order confirmation and before the start of the course. In that case, you are entitled to a refund of the price paid after deducting the online transaction charges.
For the avoidance of doubt, the cancellation period will expire 14 days after the date of the Order Confirmation.
If you start to use our services during the cancellation period (i.e., if the course commences during the 14-day cancellation period) and/or if you access the course materials via our online course spaces (i.e., via our virtual learning environment), no refund will be payable.
eMedEvents neither represents any State Medical Board nor claims to provide any online course on behalf of the State Medical Board. Subscribing to any of our CME/CE online courses is entirely at the user's discretion, and they should verify with their State Medical Board for their current re-licensure requirements.